182(top 100%)
PR articles
16.3K(top 1%)
PR citations
65(top 100%)
PR h-index
72(top 100%)
h-index
200
documents
20.5K
doc citations
1.3K
citing journals
100
times ranked

Publications

186 PR articles • 17,127 PR citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | PR Citations
#ArticleIFPR CitationsLinks
1Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines
Npj Vaccines, 2024, 9,
5.48Citations (PDF)
2CoPoP liposomes displaying stabilized clade C HIV-1 Env elicit tier 2 multiclade neutralization in rabbits
Nature Communications, 2024, 15,
13.96Citations (PDF)
3Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding site
Science Immunology, 2024, 9,
13.527Citations (PDF)
4Immunization with germ line–targeting SOSIP trimers elicits broadly neutralizing antibody precursors in infant macaques
Science Immunology, 2024, 9,
13.515Citations (PDF)
5Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies
Journal of Experimental Medicine, 2024, 221,
9.414Citations (PDF)
6Mosaic and mixed HIV-1 glycoprotein nanoparticles elicit antibody responses to broadly neutralizing epitopes
PLoS Pathogens, 2024, 20, e1012558
4.48Citations (PDF)
7Signatures of VH1-69-derived hepatitis C virus neutralizing antibody precursors defined by binding to envelope glycoproteins
Nature Communications, 2023, 14,
13.910Citations (PDF)
8Assessing immunogenicity barriers of the HIV-1 envelope trimer
Npj Vaccines, 2023, 8,
5.41Citations (PDF)
9A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern
Cell Reports Medicine, 2022, 3, 100486
6.720Citations (PDF)
10SARS‐CoV‐2 infection activates dendritic cells via cytosolic receptors rather than extracellular TLRs
European Journal of Immunology, 2022, 52, 646-655
3.215Citations (PDF)
11Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection
Cell Reports Medicine, 2022, 3, 100528
6.710Citations (PDF)
12Diagnostic performance of two serological assays for the detection of SARS-CoV-2 specific antibodies: surveillance after vaccination
Diagnostic Microbiology and Infectious Disease, 2022, 102, 115650
1.74Citations (PDF)
13Potent Induction of Envelope-Specific Antibody Responses by Virus-Like Particle Immunogens Based on HIV-1 Envelopes from Patients with Early Broadly Neutralizing Responses
Journal of Virology, 2022, 96,
3.711Citations (PDF)
14The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization
Journal of Virology, 2022, 96,
3.721Citations (PDF)
15Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients
Blood Advances, 2022, 6, 1537-1546
5.157Citations (PDF)
16High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimers
Npj Vaccines, 2022, 7,
5.423Citations (PDF)
17Distinct spatial arrangements of ACE2 and TMPRSS2 expression in Syrian hamster lung lobes dictates SARS-CoV-2 infection patterns
PLoS Pathogens, 2022, 18, e1010340
4.421Citations (PDF)
18Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller
Journal of Experimental Medicine, 2022, 219,
9.424Citations (PDF)
19A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike
Scientific Reports, 2022, 12,
3.513Citations (PDF)
20Computed tomography and [18F]-FDG PET imaging provide additional readouts for COVID-19 pathogenesis and therapies evaluation in non-human primates
IScience, 2022, 25, 104101
3.610Citations (PDF)
21Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimers
Npj Vaccines, 2022, 7,
5.45Citations (PDF)
22Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity
Journal of Allergy and Clinical Immunology, 2022, 149, 1949-1957
6.263Citations (PDF)
23Broad and ultra-potent cross-clade neutralization of HIV-1 by a vaccine-induced CD4 binding site bovine antibody
Cell Reports Medicine, 2022, 3, 100635
6.712Citations (PDF)
24Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions
Frontiers in Immunology, 2022, 13,
5.121Citations (PDF)
25Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study
PLoS Medicine, 2022, 19, e1003991
8.596Citations (PDF)
26B cells expressing IgM B cell receptors of HIV-1 neutralizing antibodies discriminate antigen affinities by sensing binding association rates
Cell Reports, 2022, 39, 111021
6.414Citations (PDF)
27A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike
Nature Communications, 2022, 13,
13.965Citations (PDF)
28Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein
Nature Communications, 2022, 13,
13.916Citations (PDF)
29Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern
Nature Communications, 2022, 13,
13.917Citations (PDF)
30Structure of the hepatitis C virus E1E2 glycoprotein complex
Science, 2022, 378, 263-269
36.476Citations (PDF)
31Fine-mapping the immunodominant antibody epitopes on consensus sequence-based HIV-1 envelope trimer vaccine candidates
Npj Vaccines, 2022, 7,
5.413Citations (PDF)
32Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate
Nature Communications, 2022, 13,
13.940Citations (PDF)
33Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
Science, 2021, 371,
36.4352Citations (PDF)
34Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
Npj Vaccines, 2021, 6,
5.447Citations (PDF)
35Virus vaccines: proteins prefer prolines
Cell Host and Microbe, 2021, 29, 327-333
15.398Citations (PDF)
36Production of HIV-1 Env-Specific Antibodies Mediating Innate Immune Functions Depends on Cognate Interleukin-21- Secreting CD4 <sup>+</sup> T Cells
Journal of Virology, 2021, 95,
3.74Citations (PDF)
37Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
Cell, 2021, 184, 1188-1200.e19
34.1194Citations (PDF)
38SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity
Science Advances, 2021, 7,
11.0139Citations (PDF)
39Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike
Cell Reports, 2021, 35, 108933
6.458Citations (PDF)
40A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection
Cell Host and Microbe, 2021, 29, 806-818.e6
15.369Citations (PDF)
41SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients
Science Immunology, 2021, 6,
13.5540Citations (PDF)
42Human Milk from Previously COVID-19-Infected Mothers: The Effect of Pasteurization on Specific Antibodies and Neutralization Capacity
Nutrients, 2021, 13, 1645
4.760Citations (PDF)
43High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages
Science Translational Medicine, 2021, 13,
12.7219Citations (PDF)
44Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva
Pathogens and Immunity, 2021, 6, 116-134
1.6123Citations (PDF)
45Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation
Biochemistry, 2021, 60, 2153-2169
2.461Citations (PDF)
46Stepwise Conformational Stabilization of a HIV-1 Clade C Consensus Envelope Trimer Immunogen Impacts the Profile of Vaccine-Induced Antibody Responses
Vaccines, 2021, 9, 750
3.015Citations (PDF)
47Influenza A Virus Hemagglutinin Trimer, Head and Stem Proteins Identify and Quantify Different Hemagglutinin-Specific B Cell Subsets in Humans
Vaccines, 2021, 9, 717
3.021Citations (PDF)
48Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers
Npj Vaccines, 2021, 6,
5.420Citations (PDF)
49Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates
PLoS Pathogens, 2021, 17, e1009736
4.427Citations (PDF)
50Intramolecular quality control: HIV-1 envelope gp160 signal-peptide cleavage as a functional folding checkpoint
Cell Reports, 2021, 36, 109646
6.414Citations (PDF)
51Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM
Nature Communications, 2021, 12,
13.971Citations (PDF)
52Convergent HIV-1 Evolution upon Targeted Destabilization of the gp120-gp41 Interface
Journal of Virology, 2021, 95,
3.73Citations (PDF)
53Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination
Science Advances, 2021, 7,
11.0105Citations (PDF)
54Infection and transmission of SARS‐CoV‐2 depend on heparan sulfate proteoglycans
EMBO Journal, 2021, 40,
7.482Citations (PDF)
55Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination
EBioMedicine, 2021, 72, 103589
9.921Citations (PDF)
56COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models
Nature Communications, 2021, 12,
13.950Citations (PDF)
57Probing Affinity, Avidity, Anticooperativity, and Competition in Antibody and Receptor Binding to the SARS-CoV-2 Spike by Single Particle Mass Analyses
ACS Central Science, 2021, 7, 1863-1873
9.234Citations (PDF)
58Structure‐guided envelope trimer design in HIV‐1 vaccine development: a narrative review
Journal of the International AIDS Society, 2021, 24,
3.640Citations (PDF)
59A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern
Npj Vaccines, 2021, 6,
5.415Citations (PDF)
60Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers
Journal of Virology, 2020, 94,
3.716Citations (PDF)
61An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain
Cell Reports, 2020, 33, 108274
6.4172Citations (PDF)
62Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity
Immunity, 2020, 53, 1272-1280.e5
23.3225Citations (PDF)
63Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens
PLoS Pathogens, 2020, 16, e1008665
4.467Citations (PDF)
64Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates
PLoS Pathogens, 2020, 16, e1008753
4.487Citations (PDF)
65Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings
PLoS Pathogens, 2020, 16, e1008817
4.4112Citations (PDF)
66Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCV
Vaccines, 2020, 8, 440
3.012Citations (PDF)
67Diverse HIV-1 escape pathways from broadly neutralizing antibody PGDM1400 in humanized mice
MAbs, 2020, 12,
10.35Citations (PDF)
68Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Science, 2020, 369, 643-650
36.41,236Citations (PDF)
69HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite
Science Advances, 2020, 6,
11.022Citations (PDF)
70Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody
Cell, 2020, 180, 471-489.e22
34.1145Citations (PDF)
71Networks of HIV-1 Envelope Glycans Maintain Antibody Epitopes in the Face of Glycan Additions and Deletions
Structure, 2020, 28, 897-909.e6
3.856Citations (PDF)
72Autologous Antibody Responses to an HIV Envelope Glycan Hole Are Not Easily Broadened in Rabbits
Journal of Virology, 2020, 94,
3.776Citations (PDF)
73Neutralizing Antibody Induction by HIV-1 Envelope Glycoprotein SOSIP Trimers on Iron Oxide Nanoparticles May Be Impaired by Mannose Binding Lectin
Journal of Virology, 2020, 94,
3.731Citations (PDF)
74Antibody Responses Elicited by Immunization with BG505 Trimer Immune Complexes
Journal of Virology, 2019, 93,
3.713Citations (PDF)
75Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimetics
PLoS Pathogens, 2019, 15, e1007920
4.477Citations (PDF)
76Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle
Nature Communications, 2019, 10,
13.9199Citations (PDF)
77HIV-1 anchor inhibitors and membrane fusion inhibitors target distinct but overlapping steps in virus entry
Journal of Biological Chemistry, 2019, 294, 5736-5746
2.236Citations (PDF)
78Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence
Nature Communications, 2019, 10,
13.9146Citations (PDF)
79Conformational Plasticity in the HIV-1 Fusion Peptide Facilitates Recognition by Broadly Neutralizing Antibodies
Cell Host and Microbe, 2019, 25, 873-883.e5
15.354Citations (PDF)
80Lower Broadly Neutralizing Antibody Responses in Female Versus Male HIV-1 Infected Injecting Drug Users
Viruses, 2019, 11, 384
3.38Citations (PDF)
81Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine Antigens
Journal of Pharmaceutical Sciences, 2019, 108, 2264-2277
3.220Citations (PDF)
82Stabilization of the V2 loop improves the presentation of V2 loop–associated broadly neutralizing antibody epitopes on HIV-1 envelope trimers
Journal of Biological Chemistry, 2019, 294, 5616-5631
2.222Citations (PDF)
83Capturing the inherent structural dynamics of the HIV-1 envelope glycoprotein fusion peptide
Nature Communications, 2019, 10,
13.938Citations (PDF)
84Presentation of HIV-1 envelope glycoprotein trimers on diverse nanoparticle platforms
Current Opinion in HIV and AIDS, 2019, 14, 302-308
3.333Citations (PDF)
85The Envelope-Based Fusion Antigen GP120C14K Forming Hexamer-Like Structures Triggers T Cell and Neutralizing Antibody Responses Against HIV-1
Frontiers in Immunology, 2019, 10,
5.12Citations (PDF)
86Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers
Immunity, 2019, 50, 241-252.e6
23.3179Citations (PDF)
87Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes
Journal of Virology, 2019, 93,
3.774Citations (PDF)
88Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell Lineages
Journal of Proteome Research, 2018, 17, 987-999
3.524Citations (PDF)
89Immunogenicity in Rabbits of HIV-1 SOSIP Trimers from Clades A, B, and C, Given Individually, Sequentially, or in Combination
Journal of Virology, 2018, 92,
3.779Citations (PDF)
90Stabilization of the gp120 V3 loop through hydrophobic interactions reduces the immunodominant V3-directed non-neutralizing response to HIV-1 envelope trimers
Journal of Biological Chemistry, 2018, 293, 1688-1701
2.242Citations (PDF)
91cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV‐1 envelope glycoprotein vaccine candidate
Biotechnology and Bioengineering, 2018, 115, 885-899
3.984Citations (PDF)
92Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier
Immunity, 2018, 49, 1162-1174.e8
23.369Citations (PDF)
93Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
Retrovirology, 2018, 15,
3.637Citations (PDF)
94Harnessing post-translational modifications for next-generation HIV immunogens
Biochemical Society Transactions, 2018, 46, 691-698
4.15Citations (PDF)
95Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins
PLoS Pathogens, 2018, 14, e1006986
4.429Citations (PDF)
96Variable Domain N-Linked Glycans Acquired During Antigen-Specific Immune Responses Can Contribute to Immunoglobulin G Antibody Stability
Frontiers in Immunology, 2018, 9,
5.156Citations (PDF)
97Short Communication: Protective Efficacy of Broadly Neutralizing Antibody PGDM1400 Against HIV-1 Challenge in Humanized Mice
AIDS Research and Human Retroviruses, 2018, 34, 790-793
1.511Citations (PDF)
98Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques
PLoS Pathogens, 2018, 14, e1006913
4.4134Citations (PDF)
99Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller
Science Translational Medicine, 2017, 9,
12.7159Citations (PDF)
100Native‐like Env trimers as a platform for <scp>HIV</scp>‐1 vaccine design
Immunological Reviews, 2017, 275, 161-182
6.6243Citations (PDF)
101Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates
Cell Reports, 2017, 18, 2175-2188
6.479Citations (PDF)
102Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches
Immunity, 2017, 46, 1073-1088.e6
23.3335Citations (PDF)
103Reducing V3 Antigenicity and Immunogenicity on Soluble, Native-Like HIV-1 Env SOSIP Trimers
Journal of Virology, 2017, 91,
3.760Citations (PDF)
104Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence Changes
Journal of Virology, 2017, 91,
3.735Citations (PDF)
105Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization
Cell Reports, 2017, 20, 1805-1817
6.4195Citations (PDF)
106Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo
Journal of Experimental Medicine, 2017, 214, 2573-2590
9.4196Citations (PDF)
107High-Throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers
Journal of Virology, 2017, 91,
3.725Citations (PDF)
108The microanatomic segregation of selection by apoptosis in the germinal center
Science, 2017, 358,
36.4271Citations (PDF)
109Opposites attract in bispecific antibody engineering
Journal of Biological Chemistry, 2017, 292, 14718-14719
2.23Citations (PDF)
110A single mutation in Taiwanese H6N1 influenza hemagglutinin switches binding to human‐type receptors
EMBO Molecular Medicine, 2017, 9, 1314-1325
7.248Citations (PDF)
111Three mutations switch H7N9 influenza to human-type receptor specificity
PLoS Pathogens, 2017, 13, e1006390
4.4108Citations (PDF)
112HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers
PLoS ONE, 2017, 12, e0181886
2.417Citations (PDF)
113The Neutralizing Antibody Response in an Individual with Triple HIV-1 Infection Remains Directed at the First Infecting Subtype
AIDS Research and Human Retroviruses, 2016, 32, 1135-1142
1.516Citations (PDF)
114Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination
Proceedings of the National Academy of Sciences of the United States of America, 2016, 113,
7.6392Citations (PDF)
115Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies
Cell Reports, 2016, 16, 2327-2338
6.4258Citations (PDF)
116Direct Probing of Germinal Center Responses Reveals Immunological Features and Bottlenecks for Neutralizing Antibody Responses to HIV Env Trimer
Cell Reports, 2016, 17, 2195-2209
6.4178Citations (PDF)
117HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds
Retrovirology, 2016, 13,
3.625Citations (PDF)
118Chemical Cross-Linking Stabilizes Native-Like HIV-1 Envelope Glycoprotein Trimer Antigens
Journal of Virology, 2016, 90, 813-828
3.735Citations (PDF)
119Cytokine-Independent Detection of Antigen-Specific Germinal Center T Follicular Helper Cells in Immunized Nonhuman Primates Using a Live Cell Activation-Induced Marker Technique
Journal of Immunology, 2016, 197, 994-1002
0.6145Citations (PDF)
120HIV-1 envelope glycoprotein immunogens to induce broadly neutralizing antibodies
Expert Review of Vaccines, 2016, 15, 349-365
4.149Citations (PDF)
121HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies
Trends in Immunology, 2016, 37, 221-232
10.6101Citations (PDF)
122Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein
Cell Reports, 2016, 14, 2695-2706
6.4281Citations (PDF)
123An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability
Nature Microbiology, 2016, 2,
16.5167Citations (PDF)
124Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C
PLoS Pathogens, 2016, 12, e1005864
4.4150Citations (PDF)
125Engineering and Characterization of a Fluorescent Native-Like HIV-1 Envelope Glycoprotein Trimer
Biomolecules, 2015, 5, 2919-2934
4.415Citations (PDF)
126Gp120/CD4 Blocking Antibodies Are Frequently Elicited in ART-Naïve Chronically HIV-1 Infected Individuals
PLoS ONE, 2015, 10, e0120648
2.46Citations (PDF)
127Colorectal Mucus Binds DC-SIGN and Inhibits HIV-1 Trans-Infection of CD4+ T-Lymphocytes
PLoS ONE, 2015, 10, e0122020
2.412Citations (PDF)
128Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies
PLoS Pathogens, 2015, 11, e1005110
4.489Citations (PDF)
129A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In Vivo
PLoS Pathogens, 2015, 11, e1005238
4.453Citations (PDF)
130Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes
Cell, 2015, 163, 1702-1715
34.1383Citations (PDF)
131Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans
Immunity, 2015, 43, 1053-1063
23.3209Citations (PDF)
132Structural Constraints Determine the Glycosylation of HIV-1 Envelope Trimers
Cell Reports, 2015, 11, 1604-1613
6.4148Citations (PDF)
133Antibody potency relates to the ability to recognize the closed, pre-fusion form of HIV Env
Nature Communications, 2015, 6,
13.9145Citations (PDF)
134HIV-1 neutralizing antibodies induced by native-like envelope trimers
Science, 2015, 349,
36.4521Citations (PDF)
135Short Communication: Virion Aggregation by Neutralizing and Nonneutralizing Antibodies to the HIV-1 Envelope Glycoprotein
AIDS Research and Human Retroviruses, 2015, 31, 1160-1165
1.515Citations (PDF)
136What Do Chaotrope-Based Avidity Assays for Antibodies to HIV-1 Envelope Glycoproteins Measure?
Journal of Virology, 2015, 89, 5981-5995
3.727Citations (PDF)
137Comprehensive Antigenic Map of a Cleaved Soluble HIV-1 Envelope Trimer
PLoS Pathogens, 2015, 11, e1004767
4.4103Citations (PDF)
138Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice
Cell, 2015, 161, 1505-1515
34.1267Citations (PDF)
139A Native-Like SOSIP.664 Trimer Based on an HIV-1 Subtype B <i>env</i> Gene
Journal of Virology, 2015, 89, 3380-3395
3.7266Citations (PDF)
140Immunosilencing a Highly Immunogenic Protein Trimerization Domain
Journal of Biological Chemistry, 2015, 290, 7436-7442
2.271Citations (PDF)
141Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer
Acta Crystallographica Section D: Biological Crystallography, 2015, 71, 2099-2108
3.176Citations (PDF)
142Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike
Nature Communications, 2015, 6,
13.998Citations (PDF)
143Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity
Journal of Virology, 2015, 89, 10383-10398
3.7174Citations (PDF)
144Reactivation of Neutralized HIV-1 by Dendritic Cells Is Dependent on the Epitope Bound by the Antibody
Journal of Immunology, 2015, 195, 3759-3768
0.64Citations (PDF)
145Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens
Proceedings of the National Academy of Sciences of the United States of America, 2015, 112, 11947-11952
7.6135Citations (PDF)
146Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers
Journal of Virology, 2015, 89, 12189-12210
3.792Citations (PDF)
147Binding of inferred germline precursors of broadly neutralizing HIV-1 antibodies to native-like envelope trimers
Virology, 2015, 486, 116-120
2.350Citations (PDF)
148Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex
Proceedings of the National Academy of Sciences of the United States of America, 2014, 111, 17624-17629
7.6377Citations (PDF)
149Early development of broadly reactive HIV-1 neutralizing activity in elite neutralizers
Aids, 2014, 28, 1237-1240
2.520Citations (PDF)
150Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers
Immunity, 2014, 40, 657-668
23.3366Citations (PDF)
151Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
Nature, 2014, 509, 55-62
38.7737Citations (PDF)
152Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers
Immunity, 2014, 40, 669-680
23.3341Citations (PDF)
153ADS-J1 inhibits HIV-1 infection and membrane fusion by targeting the highly conserved pocket in the gp41 NHR-trimer
Biochimica Et Biophysica Acta - Biomembranes, 2014, 1838, 1296-1305
2.229Citations (PDF)
154Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits
Retrovirology, 2014, 11,
3.6143Citations (PDF)
155CD4-Induced Activation in a Soluble HIV-1 Env Trimer
Structure, 2014, 22, 974-984
3.8113Citations (PDF)
156Enhanced Immunogenicity of HIV-1 Envelope gp140 Proteins Fused to APRIL
PLoS ONE, 2014, 9, e107683
2.44Citations (PDF)
157Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer
Science, 2013, 342, 1477-1483
36.4834Citations (PDF)
158Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer
Science, 2013, 342, 1484-1490
36.4701Citations (PDF)
159HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity
Retrovirology, 2013, 10,
3.639Citations (PDF)
160Broadly neutralizing antibodies against HIV-1: Templates for a vaccine
Virology, 2013, 435, 46-56
2.3110Citations (PDF)
161Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
Nature Structural and Molecular Biology, 2013, 20, 796-803
8.7341Citations (PDF)
162Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans
PLoS Pathogens, 2013, 9, e1003342
4.4286Citations (PDF)
163A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies
PLoS Pathogens, 2013, 9, e1003618
4.4980Citations (PDF)
164Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9
Proceedings of the National Academy of Sciences of the United States of America, 2013, 110, 4351-4356
7.6244Citations (PDF)
165How Can HIV-Type-1-Env Immunogenicity Be Improved to Facilitate Antibody-Based Vaccine Development?
AIDS Research and Human Retroviruses, 2012, 28, 1-15
1.571Citations (PDF)
166A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
Science, 2011, 334, 1097-1103
36.4679Citations (PDF)
167Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function
Virology, 2010, 401, 236-247
2.371Citations (PDF)
168Detailed Mechanistic Insights into HIV-1 Sensitivity to Three Generations of Fusion Inhibitors
Journal of Biological Chemistry, 2009, 284, 26941-26950
2.273Citations (PDF)
169Optimization of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins with V1/V2 Deleted, Using Virus Evolution
Journal of Virology, 2009, 83, 368-383
3.743Citations (PDF)
170Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo
Virology, 2009, 389, 108-121
2.350Citations (PDF)
171The carbohydrate at asparagine 386 on HIV-1 gp120 is not essential for protein folding and function but is involved in immune evasion
Retrovirology, 2008, 5, 10
3.644Citations (PDF)
172Only Five of 10 Strictly Conserved Disulfide Bonds Are Essential for Folding and Eight for Function of the HIV-1 Envelope Glycoprotein
Molecular Biology of the Cell, 2008, 19, 4298-4309
2.546Citations (PDF)
173Evolution Rescues Folding of Human Immunodeficiency Virus-1 Envelope Glycoprotein GP120 Lacking a Conserved Disulfide Bond
Molecular Biology of the Cell, 2008, 19, 4707-4716
2.512Citations (PDF)
174HIV-1 gp120 Mannoses Induce Immunosuppressive Responses from Dendritic Cells
PLoS Pathogens, 2007, 3, e169
4.4137Citations (PDF)
175Protein Promiscuity: Drug Resistance and Native Functions—HIV-1 Case
Journal of Biomolecular Structure and Dynamics, 2005, 22, 615-624
2.824Citations (PDF)
176Evolutionary Repair of HIV Type 1 gp41 with a Kink in the N-Terminal Helix Leads to Restoration of the Six-Helix Bundle Structure
AIDS Research and Human Retroviruses, 2004, 20, 742-749
1.521Citations (PDF)
177Title is missing!
Retrovirology, 2004, 1, 3
3.634Citations (PDF)
178Stabilization of the Soluble, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1
Journal of Virology, 2002, 76, 8875-8889
3.7450Citations (PDF)
179Oligomeric and Conformational Properties of a Proteolytically Mature, Disulfide-Stabilized Human Immunodeficiency Virus Type 1 gp140 Envelope Glycoprotein
Journal of Virology, 2002, 76, 7760-7776
3.7152Citations (PDF)
180Enhancing the Proteolytic Maturation of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins
Journal of Virology, 2002, 76, 2606-2616
3.7143Citations (PDF)
181Differential Transmission of Human Immunodeficiency Virus Type 1 by Distinct Subsets of Effector Dendritic Cells
Journal of Virology, 2002, 76, 7812-7821
3.7145Citations (PDF)
182A Recombinant Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Complex Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits Is an Antigenic Mimic of the Trimeric Virion-Associated Structure
Journal of Virology, 2000, 74, 627-643
3.7527Citations (PDF)
183Structure and topology around the cleavage site regulate post-translational cleavage of the HIV-1 gp160 signal peptide
ELife, 0, 6,
1.654Citations (PDF)
184Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens
ELife, 0, 9,
1.6166Citations (PDF)
185Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
ELife, 0, 10,
1.6103Citations (PDF)
186Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection
ELife, 0, 11,
1.616Citations (PDF)